Merck KGaA to expand life-sciences production capacity in US

Merck KGaA to expand life-sciences production capacity in US
WESPECH PTE LTD
8 Eu Tong Sen Street #14-94, The Central, Singapore (059818)
+65 315 904 24

08.12.2020

MOSCOW (MRC) -- Merck KGaA says it is investing a total of EUR40.0 million (USD48.5 million) to increase the production capacity of its facilities at Danvers, Massachusetts, and Jaffrey, New Hampshire, by the end of 2021 and in 2022, respectively, to meet "unprecedented demand" for products and services to customers developing lifesaving therapies, including COVID-19 vaccines, said Chemwe

Full article at mrcplast.com

Back

news